Introduction
A blood neutrophil concentration <1000/ml has been reported to occur in about 8% of patients in the neonatal intensive care unit (NICU) at some time during their hospital stay. [1] [2] [3] However, the incidence among the extremely low birth weight (ELBW) subpopulation is not known. To better understand the problem of low neutrophil counts in this population, we performed an historic cohort analysis of all ELBW neonates cared for in the four Intermountain Healthcare NICUs during the most recent 36 months. Our aims were to estimate the incidence of blood neutrophil counts <1000/ml in this population, to describe the age post-delivery when each case was detected, and to determine the duration of the low count and its nadir. We also sought to tabulate the treatments that were aimed at increasing the blood neutrophil concentrations, specifically intravenous immunoglobulins (IVIG) and recombinant granulocyte-colony stimulating factor (rG-CSF) administration, and to assess associations with mortality rate.
Methods
Data were collected as a deidentified limited data set from archived Intermountain Healthcare records. The information collected was limited to the complete blood counts and the information displayed in tables and figures of this report. Data were obtained for patients admitted to the NICU at McKay-Dee Hospital, Ogden, UT, USA; LDS Hospital, Salt Lake City, UT, USA; Primary Children's Medical Center, Salt Lake City, UT, USA and Utah Valley Regional Medical Center, Provo, UT, USA with a date of birth from 1 July 2002 to 30 June 2005 and with a birth weight of <1000 g. ELBW neonates who died in the first 48 h after admission to the NICU were excluded from the analysis because not all of their data are included in the Intermountain Healthcare archived data repository.
The program used for data collection was a modified subsystem of 'clinical workstation'. Clinical workstation is a web-based electronic medical record application that stores demographic and clinical information, such as history, physical examination results, laboratory data, problem lists and discharge summaries. 3M Company (Minneapolis, MN, USA) approved the structure and definitions of all data points for use within the program. The data were collected from the electronic medical record, pharmacy, laboratory systems and case mix. Case mix is the billing, coding and financial data mart used by Intermountain Healthcare. Data were managed and accessed by authorized data analysts. In addition, the medical records (paper) of each of the 28 neonates with a neutrophil count <1000/ml was reviewed by the authors to determine the laboratory tests performed to assess the cause of the low neutrophil count, to determine the stated reasons for ordering IVIG or rG-CSF, and to record what was listed as the likely underlying explanation for the low neutrophil count. The Intermountain Healthcare Institutional Review Board approved the study.
Descriptive statistics were calculated using Statit (Corvallis, OR, USA). Means and s.d. were used to express values in groups that were normally distributed. Differences in categorical variables were assessed using the w 2 test. A Student's t-test was used to assess continuous variables. Statistical significance was set as P<0.05. All hypotheses were two-tailed.
Results
Three hundred and thirty-eight neonates with a birth weight <1000 g, and a date of birth of 1 July 2002 to 30 June 2005 formed the basis of this study. All had one or more complete blood cell count (CBC)s performed. The number of CBCs per patient ranged from 1 to 123 (median, 16). One hundred and twenty-eight of the 338 ELBW neonates (38%) had one or more blood neutrophil concentrations <1000/ml. Demographic features of these 128, contrasted with the 210 ELBW neonates who did not have a low neutrophil count detected, are shown in Table 1 .
In 53% of the neonates identified with a low counts, it was detected on the first day of life (Figure 1 ), and in 74% it was detected by day 3. Only 22% were detected after the first week of life. Nine cases (7%) were not detected until 7 weeks or more.
The presence of a low neutrophil count was slightly more common at the lowest birth weights. It was found in 63% of those weighing p500 g at birth, 44% of those weighing 501 to 600 g, and in 34% of those weighing 801 g or more ( Figure 2 ). The duration of the low count ranged from less than 1 day to just over 7 days. Fifty-seven percent (73/128) had transiently low counts, Abbreviations: g; gram; PIH, pregnancy-induced hypertension; SGA; small for gestational age; wks, weeks.
Features of 338 ELBW neonates who, during their hospital stay, had no low neutrophil counts detected, vs had early-onset neutropenia (detected in the first 3 days of life), or late-onset neutropenia (detected after the first 3 days of life), or early-onset neutropenia that resolved followed by one or more episodes of late-onset neutropenia. a Early-onset neutropenia was defined as a blood neutrophil concentration <1000/ml during the first 3 days of life. Patients listed in this column had early-onset neutropenia, but they did not subsequently develop late-onset neutropenia. b Late-onset neutropenia was defined as a blood neutrophil concentration <1000/ml, detected after the first 3 days of life. Patients listed in this column had a normal neutrophil concentration during the first 3 days of life, but developed low neutrophil counts sometime between 4 days of age and hospital discharge.
because a repeat count performed within 24 h was >1000/ml, but 43% continued to have this finding for more than 1 day. The longest duration observed was 7.5 days.
The lowest neutrophil count recorded on each subject is shown in Figure 3 . In just under half (48%) of the cases the lowest recorded count was p500/ml. In 21% it was in the range of 800 to 1000/ml.
The presence of a count <1000/ml did not correlate with mortality rate; neither did the severity (lowest recorded count) or its duration (days). For instance, the mortality rate among those with a lowest recorded count of p500/ml (8/45 died 17.8%) was not significantly higher than among those with a lowest recorded count X750/ml (3/27 died 11.1%, P ¼ 0.27). However, the highest morality rate group was those with early-onset bacterial sepsis and a neutrophil count <1000/ml, where four of six died.
Most of the neutropenic ELBW neonates did not have either IVIG or rG-CSF administered (Table 2) . When IVIG was used, it was ordered in accordance with our published guidelines 100% of the time. 4 When rG-CSF was used, it was ordered in accordance with our guidelines 69% of the time. 4 The likely explanations discovered as underlying antecedents, or causes of the low counts, are shown in Table 3 . The majority of the cases detected in the first 3 days after birth were associated with small for gestational age (SGA) or pregnancy-induced hypertension (PIH). The majority of the cases detected after the first 3 days were associated with necrotizing enterocolitis (NEC) or nosocomial infection. Over 1/3 of the cases had no apparent explanation for the low counts or were incompletely evaluated. None of the patients had studies carried out to determine whether alloimmune or autoimmune neutropenia were present. None had a count that stayed below 1000/ml for more than 7.5 days, and thus, no cases of severe chronic neutropenia (SCN) were detected. Figure 1 The day of life when each episode of neutropenia (blood neutrophil concentration <1000/ml) was recognized. Figure 2 Incidence of a blood neutrophil count <1000/ml, among ELBW neonates, according to birth weight. Figure 3 The lowest blood neutrophil concentration recorded is shown for 128 ELBW neonates with one or more counts <1000/ml. Abbreviations: ELBW, extremely low birth-weight; IVIG, intravenous immunoglobulins; rG-CSF, recombinant granulocyte-colony stimulating factor. a Guidelines for using IVIG ¼ ANC <1000/ml, bacterial infection proven or highly likely, hypotension and significant clinical deterioration. Dose ¼ 750 mg/kg. 4 b Guidelines for using rG-CSF ¼ Known to be a case of severe chronic neutropenia (SCN), or ANC <500/ml for 2 days or more, or ANC <1000/ml for 5 days or more. Dose ¼ 10 mg/kg/day for 3 days. Abbreviations: NEC, necrotizing enterocolitis; PIH, pregnancy-induced hypertension; SGA; small for gestational age. The likely underlying causes explaining the presence of 153 episodes of neutropenia among 128 ELBW neonates are shown. Ninety-five episodes occurred in the first 3 days of life and 58 after the first 3 days. In some instances, more than one contributing factor was ascribed. Therefore, the sum of each column exceeds 100%. a TAR syndrome. The neutropenia spontaneously resolved after 3 days, without IVIG or rG-CSF treatment. b All three patients were receiving amphotericin. It was not clear whether the neutropenia should be ascribed to the fungal sepsis or the amphotericin. In each case, the neutropenia developed at least 2 days after the onset of treatment with amphotericin.
c Cutaneous herpes simplex.
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Discussion
In this cohort analysis of 338 ELBW neonates, we found a low neutrophil count to be very common, with an incidence five times that reported among the general NICU population. [1] [2] [3] The majority of cases were detected during the first days following birth. These patients were commonly SGA or born after PIH. Some patients were SGA and also were born to a mother with PIH, whereas others had only one or the other antecedent. We detected no differences between the severity or duration of the low count associated with SGA vs that associated with PIH.
The medical significance of neutropenia associated with SGA/ PIH is unclear. Some reports indicate that this increases the likelihood of developing a perinatal infection, 5, 6 whereas other reports suggest it does not convey this propensity. [7] [8] [9] Although still somewhat controversial, IVIG or rG-CSF administration have not been generally recommended as routine treatments for this variety of neutropenia, which usually spontaneously resolves after 2 or 3 days. [10] [11] [12] [13] [14] [15] In otherwise well-appearing term babies who have abnormally low blood neutrophil concentrations in the first days of life, the diagnosis of alloimmune neutropenia should be considered, 16, 17 and rarely cases of autoimmune neutropenia are found. 18, 19 However, we discovered no cases where immune-mediated mechanisms were diagnosed, or even looked for. We speculate that some of the early-onset neutropenia with no recognized explanation may have indeed been on an alloimmune basis. Perinatal infection with bacteria, viruses or fungi can cause neutropenia. 2, 20 We speculate that such infections, undocumented, may have been responsible for some of the cases of undetermined cause. Genetic errors or syndromes can cause neutropenia, 20 but we found only one such case, which was in a neonate with Thrombocytopenia and Absent Radii syndrome. Maternal chemotherapy can be a cause of neonatal neutropenia 21 but we identified no such cases.
When the onset of neutropenia was after the first 3 days, it was generally associated with NEC or nosocomial infection. These varieties of neonatal neutropenia are well described. 2, 20, [22] [23] [24] [25] However, we found that 43% of the late-onset cases had no recognized underlying cause. Some of these might have been the benign variety of neutropenia sometimes termed, 'idiopathic neutropenia of prematurity'. 26, 27 That variety probably does not constitute a significant host-defense deficiency, because such patients generally maintain a bone marrow neutrophil reserve that can be mobilized as needed to contend with bacteria. 27 IVIG administration has sometimes been advocated for septic, neutropenic and neonates, with the hope of providing opsonic antibody against infecting organisms, but its use has not been well defined. 28 In a recent Cochrane Review of this usage of IVIG, Olson and Lacy concluded that whereas more study is needed, the available data suggest a benefit in reducing mortality. 28 In a consensus development process, we suggested that the use of IVIG was reasonable in neonates who had a blood neutrophil count <1000/ml and proven or very likely bacterial sepsis and shock syndrome. 4 In the present study we observed that IVIG was always used in accordance with this recommendation. However, it remains unclear how much benefit the patients derived from this practice.
rG-CSF has been approved for use among patients with SCN. 20 However, it has generally not been regarded as useful in treating neonates with sepsis and neutropenia. 29 A Cochrane Review of this usage of rG-CSF concludes that whereas more study is needed, the available data suggest that it has no benefit in reducing mortality. 29 In a consensus development process, we suggested that rG-CSF should not be routinely used for neonates with sepsis and neutropenia, but that it should be reserved for neonates who may indeed have a variety of SCN whose neutrophil counts are <500/ul for 2 days or more, or <1000/ml for 5 days or more. 4 In the present study we observed that when rG-CSF was used, it was given in accordance with this recommendation in 69% of the cases. As with IVIG usage, it is unclear from this study how much benefit these patients derived from rG-CSF administration.
In general, we found low neutrophil counts among ELBW neonates to be transient, generally lasting only 1 day, and rarely more than 3. We failed to find an association between low counts and mortality rate, except in the circumstance of proven earlyonset bacterial infection where it was associated with a poor outcome. In all other instances, the presence, severity and duration of low counts had no relationship with mortality rate. When evaluating ELBW neonates who have low neutrophil counts, broad spectrum systemic antibiotics are generally used initially, because of the possibility that neutropenia is a manifestation of bacterial infection. 4, 20 However, only for those with early-onset sepsis and shock syndrome do we advocate IVIG administration 4 and only for those with very low counts that persist for many days, and might indeed have SCN, do we advocate rG-CSF administration. 4 One of the important issues unaddressed by this study is the function of neutrophils of ELBW infants. Indeed, the host-defense deficiency posed by a low neutrophil count in these patients might be compounded by reduced neutrophil function. Ineffective chemotaxis is probably the best-studied neutrophil deficiency of preterm neonates, 30 but extensive studies of neutrophil function in ELBW neonates have not been reported.
As so many of the cases we reviewed were of unknown causation, or were incompletely evaluated, we judge that more consistency is needed for evaluating low neutrophil counts in ELBW neonates. Perhaps some consistency must come in the form of writing reasonable algorithm-based approaches, but some consistency can come from following guidelines already published. 4, 20 As more effort is expended in improving the outcome of ELBW infants, definition is needed regarding which cases of neutropenia are truly innocuous, and which are likely to benefit from IVIG, rG-CSF or other interventions.
